| Identification | |
| Name: | Benzamide,2-hydroxy-N-(4-hydroxyphenyl)- |
| Synonyms: | Osalmid;2-Hydroxy-N-(4-hydroxyphenyl)benzamide;4'-Hydroxysalicylanilide;Auxobil;BRN 2941480;Bilene;Bilocol;Hydroxyphenyl salicylamide;N'-Salicyloyl-p-aminophenol;N-(4-Hydroxyphenyl)salicylamide;NSC 93960;Oksafenamid;Salmidochol;UNII-89741L759Z;p-Hydroxyphenylsalicylamide;Benzamide, 2-hydroxy-N-(4-hydroxyphenyl)- (9CI);Salicylanilide, 4'-hydroxy-; |
| CAS: | 526-18-1 |
| EINECS: | 208-385-9 |
| Molecular Formula: | C13H11NO3 |
| Molecular Weight: | 229.23 |
| InChI: | InChI=1/C13H11NO3/c15-10-7-5-9(6-8-10)14-13(17)11-3-1-2-4-12(11)16/h1-8,15-16H,(H,14,17) |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.387 g/cm3 |
| Refractive index: | 1.71 |
| Appearance: | White crystal |
| Specification: |
Osalmid (526-18-1) is a odorless white crystalline powder, almost insoluble in cold water and acetic acid, slightly soluble in hot water, benzene and toluene, soluble in methanol, ethanol and propanol. It is also known as Osalmid [INN:JAN] ; Osalmide ; 2-Hydroxy-N-(4-hydroxyphenyl)benzamide ; 3-13-00-01137 (Beilstein Handbook Reference) ; 4'-Hydroxysalicylanilide ; Auxobil ; Bilene ; Bilocol ; Dribazil ; Driol ; Driol-labaz ; Enidran ; Hydroxyphenyl salicylamide ; L 1718 ; N'-Salicyloyl-p-aminophenol ; N-(4-Hydroxyphenyl)salicylamide ; N-(p-Hydroxyphenyl)salicylamide ; NSC 93960 ; Oksafenamid ; Osalmida ; Osalmida [INN-Spanish] ; Osalmide [INN-French] ; Osalmidum ; Osalmidum [INN-Latin] ; Oxaphenamid ; Oxaphenamide ; Oxaphenamidum ; PHPS ; Salmidochol ; Saryuurin ; UNII-89741L759Z ; p'-Hydroxysalicylanilide ; p-Hydroxyphenylsalicylamide ; 4'-Hydroxysalicylanilide ; Benzamide, 2-hydroxy-N-(4-hydroxyphenyl)- ; Benzamide, 2-hydroxy-N-(4-hydroxyphenyl)- (9CI) ; Salicylanilide, 4'-hydroxy- . Osalmid (526-18-1) is a kind of gallbladder drugs for the treatment of biliary tract inflammation, cholecystitis. |
| Safety Data | |
 |
|
